Showing results (561-570 of 786) with videos related to

Sort By:
Pageof 79
In Silico Pharmacology|August 2, 2026
Integrated data mining, network pharmacology and molecular docking to explore the medication rules and mechanism of traditional Chinese medicine compound in the treatment of acneWanyun Zhu, Ziyan Cheng, Qimei Xie, et al.
In Silico Pharmacology|August 19, 2026
Exploring the anti-Helicobacter pylori activity of Guluchyadi Kashayam through in-vitro and in-silico analysisPriya Venugopal, Abel John Koshy, Anuroopa G Nadh, et al.
In Silico Pharmacology|September 8, 2026
Structure-based virtual screening, multi-score docking, and molecular dynamics simulation of novel small molecules targeting the epidermal growth factor receptor for potential management of oral squamous cell carcinomaMuhammad Bilal Azmi, Tehreem Zia, Uzma Asif, et al.
In Silico Pharmacology|September 8, 2026
An integrated computational and experimental approach reveals atranorin as a promising therapeutic for non-small cell lung cancer A549 cell lineSaparja Saha, Sayanti Karmakar, Shremayi Chatterjee, et al.
In Silico Pharmacology|September 8, 2026
Structural basis for Kisspeptin-10 selectivity toward KISS1R: computational insightsMaria A Netesa, Sarng S Pyurveev, Andrei A Lebedev, et al.
In Silico Pharmacology|August 31, 2026
A description of the structural and functional impacts of the SCID- and OS-associated variants on RAG1 through MD simulationsAsli Kutlu, Sinem Firtina, Begüm Işikgil
In Silico Pharmacology|September 16, 2026
Enhanced antioxidant and anti-inflammatory activities of BerbiQ compared with berberine and silymarin: integrated in vitro and in silico investigationsV Anantha Bhairavi, V Anantha Narayanan, Sreelakshmi Aravind Kuppadakath, et al.
In Silico Pharmacology|September 16, 2026
In silico analysis of MALAT1 and H19 lncRNA interactions with the diabetes-related proteins ASK1 and YAP1Leonardo Elías Cabrera-Nájera, Olga Nelly Rodríguez-Peña, Cesar Mateo Flores-Ortíz, et al.
In Silico Pharmacology|September 21, 2026
Deciphering the interaction landscape of NDM-1 with a novel β-lactam-based inhibitor: implications for rational drug designSaraswathy Nagendran, Sugunadevi Sakkiah
In Silico Pharmacology|September 26, 2026
Discovery of potential RdRp catalytic domain inhibitors against Crimean-Congo hemorrhagic fever virus from Andrographis paniculata via LC-MS/MS profiling and computational approachesAbdul Rehman Riaz, Muhammad Islam, Hamid Saeed, et al.
Pageof 79